Sort
48,018 grants matching “immunotherapy”
Protection Against Nosocomial Infections After Severe Burn Injury Through Trained Immunity
$432,500Julia K. Bohannon · Vanderbilt University Medical Center · R35 · FY2023 · GM
Protection Against Nosocomial Infections After Severe Burn Injury Through Trained Immunity
$432,500Julia K. Bohannon · Vanderbilt University Medical Center · R35 · FY2025 · GM
Protection Against Nosocomial Infections After Severe Burn Injury Through Trained Immunity
$432,500Julia K. Bohannon · Vanderbilt University Medical Center · R35 · FY2022 · GM
Targeting mechanisms of immune evasion in chemotherapy-induced senescent cells
$432,347James Jackson · Tulane University Of Louisiana · R01 · FY2022 · CA
Directing the metabolic fate of CAR T cells
$432,308Carl H. June · University Of Pennsylvania · R01 · FY2020 · CA
Directing the metabolic fate of CAR T cells
$432,308Carl H. June · University Of Pennsylvania · R01 · FY2021 · CA
Directing the metabolic fate of CAR T cells
$432,308Carl H. June · University Of Pennsylvania · R01 · FY2018 · CA
Understand & overcome resistance to PD-1
$432,274Paul Nghiem · University Of Washington · P01 · FY2025 · CA
Targeting TREM2 to boost anti-cancer therapy
$432,265Marco Colonna · Washington University · R01 · FY2023 · CA
Targeting TREM2 to boost anti-cancer therapy
$432,265Marco Colonna · Washington University · R01 · FY2022 · CA
CEA TARGETED IMMUNOTHERAPEUTICS
$432,259Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P01 · FY2009 · CA
Single-Cell Analysis of the HIV/SIV Reservoir
$432,250Dan H. Barouch · Beth Israel Deaconess Medical Center · R01 · FY2023 · AI
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
$432,171Scott Rothbart · Coriell Institute For Medical Research · P50 · FY2021 · CA
Treatment of Autoimmune Disease by Costimulatory Signal*
$432,118Brigham And Women'S Hospital · U19 · FY2003 · AI
Functional characterization and rational therapeutic targeting of 18q DNA copy number gains in diffuse large B-cell lymphoma
$432,113Michael Richard Green · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
HIV persistence and treatment response in Kaposi sarcoma
$432,098Edus Houston Warren · Fred Hutchinson Cancer Center · R21 · FY2025 · CA
Ex vivo Analysis of Autoreactive T Cells from Patients with Multiple Sclerosis
$432,036John Christopher Love · Dana-Farber Cancer Inst · P01 · FY2014 · AI
Mechanisms of immunotherapy response and resistance in pancreatic ductal adenocarcinoma
$431,993Ingunn Margarete Stromnes · University Of Minnesota · R01 · FY2025 · CA
Insonation of ultrasound microbubbles at low frequency to enhance image-guided therapy
$431,977Katherine W Ferrara · Stanford University · R01 · FY2022 · CA
Monitoring Listeria in vivo using 18FDG and PET scan
$431,970Claudia Gravekamp · Albert Einstein College Of Medicine · R21 · FY2024 · CA
Rewired Metabolism and Immunosuppression in MYCN-driven Neuroblastoma
$431,968Eveline Barbieri · Baylor College Of Medicine · R01 · FY2024 · CA
Role of T Cell Immunity in Primate AIDS
$431,943Emory University · R01 · FY2003 · AI
Targeting colorectal cancer stem cells with ALDH1B1 antagonists
$431,906James K Chen · Stanford University · R01 · FY2023 · CA
Basic Medical Research Training in Oncology
$431,867Olufunmilayo I Olopade · University Of Chicago · T32 · FY2018 · CA
ALDH Inhibition as Modulator of Tumor Immunobiology
$431,843Ronald J Buckanovich · Magee-Women'S Res Inst And Foundation · R01 · FY2022 · CA